Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
American Family Physician|January 31, 2009
Common pigmentation disordersScott Plensdorf, Joy MartinezAmerican Family Physician|February 13, 2018
Pigmentation Disorders: Diagnosis and ManagementScott Plensdorf, Maria Livieratos, Nabil DadaJournal of Virological Methods|October 10, 2017
Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complexFelix Wussow, Flavia Chiuppesi, Zhuo Meng, et al.Viral Immunology|October 13, 2007
Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adultsWendi Zhou, Madeva Sharma, Joy Martinez, et al.Virology|April 8, 2006
Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individualsMadeva C Sharma, Wendy Zhou, Joy Martinez, et al.Journal of Virology|November 16, 2012
A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaquesFelix Wussow, Yujuan Yue, Joy Martinez, et al.Vaccine|October 20, 2006
Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1Zhongde Wang, Corinna La Rosa, Zhongqi Li, et al.The Journal of Infectious Diseases|January 4, 2008
Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus diseaseCorinna La Rosa, Aparna Krishnan, Jeff Longmate, et al.Journal of Virology|August 17, 2005
Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptidesLudmila Krymskaya, Madeva C Sharma, Joy Martinez, et al.Vaccine|December 9, 2009
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccinesZhongde Wang, Joy Martinez, Wendi Zhou, et al.Pageof 3